Three humans, eight AI team members, one product. The multi-agent collaboration pattern Stark Insider readers have been ...

Zaya1-8B is a huge shift in LLMs, and the results are impressive.

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Chris Gibson built the pioneering AI biotech Recursion Pharmaceuticals on a foundation of bold promises. But after more than a decade at the helm, Gibson stepped down as CEO in November 2025. And his ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Researchers at the University of Illinois Urbana-Champaign have developed a way to stack high-performance ...

UIUC and Stanford's RecursiveMAS lets AI agents collaborate in embedding space instead of text, cutting token usage by 75% ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Recursive Superintelligence, founded by former Google, Meta and OpenAI researchers, is part of a growing effort to automate the creation of artificial intelligence. By Cade Metz Reporting from San ...

Using AI chatbots for even just 10 minutes may have a shockingly negative impact on people’s ability to think and problem-solve, according to a new study from researchers at Carnegie Mellon, MIT, ...

People everywhere are using AI to get creative, spend more time with loved ones and ditch mundane tasks — all things they wouldn’t have even imagined a year ago, before generative AI became widely ...